搜尋結果
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double ...
CNBC· 4 小時前... the most valuable company in Europe last year due to the blockbuster success of its ... ...
Ryan Garcia: What’s Ostarine And How Could A Boxer Use It To Cheat?
Forbes· 1 日前Ryan Garcia tested positive twice for the banned substance Ostarine the day before and the day ...
Wegovy, Mounjaro prices cut as British pharmacies compete for weight-loss patients
Reuters· 5 小時前Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain ...
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 5 小時前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
Wegovy Is Available Again After Shortages, FDA Says—But Supplies Are Still Limited
Forbes· 2 日前The 1.7 milligram (mg) dose of Wegovy is listed as available on the FDA’s drug shortage ...
Amgen investors await weight-loss drug data
Reuters· 23 小時前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 2 日前, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales ... ...
Novo Nordisk Lifts Guidance as Blockbuster Drug Demand Shows No Signs of Abating
The Wall Street Journal· 4 小時前The Danish pharmaceutical giant raised its full-year guidance to reflect better pricing in the U.S. and as global demand ...
Novo Nordisk raises outlook fuelled by obesity drug demand
Reuters· 4 小時前, opens new tab raised its 2024 outlook on Thursday and delivered better-than-expected ...
Novo Boosts Outlook as More Patients Start on Wegovy for Obesity
Bloomberg· 5 小時前Have a confidential tip for our reporters? Novo Nordisk A/S is shipping more introductory doses ...